Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Even Warren Buffett Doesn’t Want to Hang on to DAL Stock

By Will Ashworth, InvestorPlace Contributor
According to Berkshire’s 2019 annual shareholder letter, the company’s cost for 70.9 million shares of Delta stock was $3.125 billion. That’s an average of $44.07 a share. At the end of the year, Berkshire’s Delta investment was up 33%.

10 Overleveraged Stocks to Sell For Peace of Mind

By Will Ashworth, InvestorPlace Contributor
Corporations of all sizes are piling on the debt to survive the novel coronavirus. Here are 10 stocks to sell who’ve only made things worse.

A Trifecta of Pain Awaits Chesapeake Energy

By InvestorPlace Research Staff
Chesapeake made unfortunate headlines when rumors circulated that it’s preparing bankruptcy filings. Here are three reasons why you need to give up on CHK stock now.

American Airlines Is in Trouble: Stay Away From AAL Stock

By Mark R. Hake, CFA
American Airlines has negative equity and is likely to post more debt and losses, so wise investors should stay clear of AAL stock for now.

Warren Buffett Sold Delta Airlines Stock for a Loss. Should You?

By David Moadel, InvestorPlace Contributor
If the Oracle of Omaha's dumping Delta Airlines, maybe it's time to reconsider your position in DAL stock as well.

4 Good Reasons to Avoid Twitter Stock After Disappointing Earnings

By Luke Lango, InvestorPlace Senior Investment Analyst
Twitter's earnings were not good. They were so bad that investors should avoid TWTR stock for now. Here's exactly why.

4 Struggling Mega-Cap Stocks to Sell Now

By William Roth, InvestorPlace Market Strategist
These mega-cap names are stocks to sell now as the novel coronavirus weighs on quarterly earnings and upside potential.

iBio Stock Is Too Risky

By Todd Shriber, InvestorPlace Contributor
IBIO stock gets attention because of iBio's foray into treating the coronavirus, but investors who want that exposure should look elsewhere.

Lyft Has Several Battles to Fight Beyond the Pandemic

By Faizan Farooque, InvestorPlace Contributor
Ride-hailing investments like Lyft stock were already facing difficulties prior to the coronavirus pandemic. In its aftermath, those questions become harder to answer.

Take Profits Now, Because AMD Stock Gains Have Out

By Tom Taulli, InvestorPlace Contributor
AMD reported a solid quarter. But the guidance was not encouraging. It looks like demand for both the enterprise and consumer markets will come under pressure.

Fewer Babies Means Less Love for Mattel

By Josh Enomoto, InvestorPlace Contributor
Though the discount in MAT stock may attract speculators, you should stay away. Simply, the fundamentals still don’t justify the price.

Marathon Won’t Get Help From Q1 Earnings

By Will Ashworth, InvestorPlace Contributor
MRO stock owners should be very concerned as Marathon Oil prepares to reports first-quarter results May 6 after the markets close.

There’s More Pain Ahead for Halliburton Stock in the Coming Quarters

By Faisal Humayun, InvestorPlace Contributor
Halliburton stock should benefit from strong fundamentals and liquidity. But that won't likely help it weather the coming revenue decline.

It May Be Too Early to Buy Carnival Stock

By Tezcan Gecgil, InvestorPlace Contributor
Unless you are a high-risk investor, it may still be too early to invest in CCL stock at this point, as the company is facing tough problems.

Why Investors Should Still Take a Hard Pass on Tilray

By InvestorPlace Research Staff
Tilray has poor fundamentals and is more than 95% off its highs. Investors should avoid TLRY stock in favor of other cannabis stocks.

Beyond Meat Stock Is a Classic Bull Trap

By InvestorPlace Research Staff
Beyond Meat has jumped higher due to real meat supply chain disruptions. However, this dynamic makes BYND stock nothing more than a bull trap.

Remdesivir Isn’t Enough for United Airlines Stock to Fight the Turbulence

By Josh Enomoto, InvestorPlace Contributor
UAL stock received a sizable lift from a promising treatment for the coronavirus. However, this is a bull trap that investors should avoid.

Don’t Expect Good Things for BYND Stock as Earnings Approach

By Chris Markoch, InvestorPlace Contributor
After cllimbing over 50% in the past month, investors are wondering if BYND stock has room to move higher after their earnings report.

The Fundamentals Say the Time to Buy INO Stock Has Passed

By Bret Kenwell, InvestorPlace Contributor
Inovio stock doesn't have the fundamentals to back up its bullish-leaning technicals. Here's what do with INO stock as a result.
Load More Articles